Skip to main content
Clinical Trials/CTRI/2020/10/028420
CTRI/2020/10/028420
Not yet recruiting
未知

Influence of smart phone application based intervention on medication adherence in patients with chronic diseases-A Randomized controlled trial.

JIPMER Puducherry0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C910- Acute lymphoblastic leukemia [ALL]Health Condition 2: C921- Chronic myeloid leukemia, BCR/ABL-positiveHealth Condition 3: I10- Essential (primary) hypertensionHealth Condition 4: C50- Malignant neoplasm of breastHealth Condition 5: C34- Malignant neoplasm of bronchus andlungHealth Condition 6: C15-C26- Malignant neoplasms of digestive organsHealth Condition 7: E11- Type 2 diabetes mellitus
Sponsor
JIPMER Puducherry
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Diabetes mellitus and Systemic hypertension:
  • 1\. Patients with type 2 diabetes (T2DM) aged greater than 18years irrespective of gender, who are on stable dose of anti\-diabetic medication for at least 1 month
  • 2\. Patients with Systemic hypertension aged greater than 18years irrespective of gender, who are on stable dose of antihypertensive medication for at least 1 month
  • 3\. Patients with concomitant type 2 diabetes and systemic hypertension
  • 4\. Patients who are able to read Tamil/ English/ Hindi
  • 5\. Patients who are owning and operating a smartphone at least for 3 months
  • 6\. Patients who are using the smartphone daily, having the phone within reach and checking it atleast three times a day
  • 7\. Patients who have not used any medication adherence application till now
  • 8\. Patients with gastro\-intestinal malignancies receiving capecitabine
  • 9\. Patients with chronic myeloid leukemia receiving imatinib

Exclusion Criteria

  • Diabetes mellitus and Systemic hypertension:
  • 1\. Diabetic patients on insulin therapy
  • 2\. Patients with secondary hypertension or gestational hypertension
  • 3\. Patients with hypertensive emergency/ urgency
  • 4\. Pregnant or lactating women
  • 5\. Patients with hepatic/ renal impairment
  • 6\. Patients with h/o Coronary artery disease, cerebrovascular disease, stroke, Myocardial Infarction(MI) in the past 3 months
  • 7\. Patients who had participated in any other trials in the past 3 months
  • 8\. Patients with h/o surgery in the past 3 months or planning for surgery in the next 3 months
  • 9\. Patients on herbal medications

Outcomes

Primary Outcomes

Not specified

Similar Trials